Indicative Announcement on Convening the 2025 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on Convening the 2025 Annual General Meeting
Filed with SSE · · 5 pages · Chinese
Release
Shanghai Kaikai Industrial Co., Ltd. on 6ix
Earlier from Shanghai Kaikai Industrial
- Announcement on Progress in Capital Increase to Wholly-owned Subsidiary Shanghai Leiyunshang Pharmaceutical West District Co., Ltd.
- Announcement on Attending Annual Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2026
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Actual Amount Incurred in Daily Related Party Transactions in 2025 and Daily Related Party Transactions in 2026
- Announcement on Using Idle Self-owned Funds to Purchase Bank Financial Products
Later from Shanghai Kaikai Industrial
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Completion of Capital Increase to Wholly-owned Subsidiary Shanghai Leiyunshang Pharmaceutical West District Co., Ltd.
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Expected Increase in Semi-annual Performance for 2026
- Announcement on the Authorization of the Wholly-Owned Subsidiary, SHANGHAI LEIYUNSHANG PHARMACEUTICAL CO,. LTD., to Acquire the Minority Equity Interest in Its Controlled Subsidiary, Shanghai Leixi Jingyi Supply Chain Management Co., Ltd.
Follow Shanghai Kaikai Industrial into a list and get an email when it puts out news.
Follow Shanghai Kaikai Industrial